BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3022623)

  • 1. Effect of suramin on serum viral replication in feline leukemia virus-infected pet cats.
    Cogan DC; Cotter SM; Kitchen LW
    Am J Vet Res; 1986 Oct; 47(10):2230-2. PubMed ID: 3022623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of continuous oral diethylcarbamazine treatment on lymphocyte counts of feline leukemia virus-infected cats.
    Kitchen LW; Mather FJ; Cotter SM
    J Clin Lab Immunol; 1988 Dec; 27(4):179-81. PubMed ID: 2855080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A; Grófová M
    Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H; Pedersen NC; Theilen GH
    Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases.
    Essex M; Cotter SM; Hardy WD; Hess P; Jarrett W; Jarrett O; Mackey L; Laird H; Perryman L; Olsen RG; Yohn DS
    J Natl Cancer Inst; 1975 Aug; 55(2):463-7. PubMed ID: 169377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
    Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A
    J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tears for diagnosis of feline leukemia virus infection.
    Hawkins EC; Johnson L; Pedersen NC; Winston S
    J Am Vet Med Assoc; 1986 May; 188(9):1031-4. PubMed ID: 3011717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of virus-positive and virus-negative cases of feline leukemia and lymphoma.
    Francis DP; Cotter SM; Hardy WD; Essex M
    Cancer Res; 1979 Oct; 39(10):3866-70. PubMed ID: 225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
    Hoover EA; Olsen RG; Mathes LE; Schaller JP
    Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feline leukemia virus (FeLV) and FeLV-associated diseases in cats: a review].
    Weijer K; UytdeHaag F; Osterhaus AD
    Tijdschr Diergeneeskd; 1987 Jun; 112(12):726-37. PubMed ID: 3039686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive reactions associated with anti-mouse activity in serotests for feline leukemia virus antigen.
    Lopez NA; Jacobson RH
    J Am Vet Med Assoc; 1989 Sep; 195(6):741-6. PubMed ID: 2551863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
    Snyder HW; Singhal MC; Hardy WD; Jones FR
    J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diethylcarbamazine on serum antibody to feline oncornavirus-associated cell membrane antigen in feline leukemia virus cats.
    Kitchen LW; Cotter SM
    J Clin Lab Immunol; 1988 Feb; 25(2):101-3. PubMed ID: 2836593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic profiles of cats with persistent, naturally acquired feline leukemia virus infection.
    Reimann KA; Bull RW; Crow SE; Coffman P; Raskin RE
    Am J Vet Res; 1986 Sep; 47(9):1935-9. PubMed ID: 3021028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline leukemia in Israel: prevalence of antibody to feline oncornavirus-associated cell membrane antigen in stray cats.
    Cohen D; Essex M
    Intervirology; 1980; 13(6):342-7. PubMed ID: 6252115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of feline leukemia virus from clinical specimens.
    Hinshaw VS; Blank HF
    Am J Vet Res; 1977 Jan; 38(1):55-7. PubMed ID: 189647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic abnormalities preceding apparent recovery from feline leukemia virus infection.
    Lester SJ; Searcy GP
    J Am Vet Med Assoc; 1981 Mar; 178(5):471-4. PubMed ID: 6263848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of feline embryo adherent cells with feline leukemia virus: feline oncornavirus-associated cell membrane antigen expression and morphologic transformation.
    Rice JB; Schaller JP; Lewis MG; Mathes LE; Hoover EA; Olsen RG
    J Natl Cancer Inst; 1981 Jan; 66(1):89-96. PubMed ID: 6256575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.